373 related articles for article (PubMed ID: 16369015)
1. Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.
Kirkham LA; Kerr AR; Douce GR; Paterson GK; Dilts DA; Liu DF; Mitchell TJ
Infect Immun; 2006 Jan; 74(1):586-93. PubMed ID: 16369015
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines based on genetically detoxified derivatives of pneumolysin fail to protect mice against challenge with Streptococcus pneumoniae.
Ferreira DM; Arêas AP; Darrieux M; Leite LC; Miyaji EN
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):291-7. PubMed ID: 16487311
[TBL] [Abstract][Full Text] [Related]
3. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung.
Arévalo MT; Xu Q; Paton JC; Hollingshead SK; Pichichero ME; Briles DE; Girgis N; Zeng M
FEMS Immunol Med Microbiol; 2009 Apr; 55(3):346-51. PubMed ID: 19291171
[TBL] [Abstract][Full Text] [Related]
4. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines.
Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y
Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076
[TBL] [Abstract][Full Text] [Related]
5. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
[TBL] [Abstract][Full Text] [Related]
6. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccines: an update on current strategies.
Bogaert D; Hermans PW; Adrian PV; Rümke HC; de Groot R
Vaccine; 2004 Jun; 22(17-18):2209-20. PubMed ID: 15149779
[TBL] [Abstract][Full Text] [Related]
8. Vaccination with a Streptococcus pneumoniae trivalent recombinant PcpA, PhtD and PlyD1 protein vaccine candidate protects against lethal pneumonia in an infant murine model.
Verhoeven D; Xu Q; Pichichero ME
Vaccine; 2014 May; 32(26):3205-10. PubMed ID: 24731814
[TBL] [Abstract][Full Text] [Related]
9. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.
Briles DE; Hollingshead SK; Paton JC; Ades EW; Novak L; van Ginkel FW; Benjamin WH
J Infect Dis; 2003 Aug; 188(3):339-48. PubMed ID: 12870114
[TBL] [Abstract][Full Text] [Related]
10. Structure-guided antigen engineering yields pneumolysin mutants suitable for vaccination against pneumococcal disease.
Oloo EO; Yethon JA; Ochs MM; Carpick B; Oomen R
J Biol Chem; 2011 Apr; 286(14):12133-40. PubMed ID: 21296887
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.
Dessing MC; Florquin S; Paton JC; van der Poll T
Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480
[TBL] [Abstract][Full Text] [Related]
12. Protection against bacteremic pneumococcal infection by antibody to pneumolysin.
Musher DM; Phan HM; Baughn RE
J Infect Dis; 2001 Mar; 183(5):827-30. PubMed ID: 11181163
[TBL] [Abstract][Full Text] [Related]
13. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
Chen A; Mann B; Gao G; Heath R; King J; Maissoneuve J; Alderson M; Tate A; Hollingshead SK; Tweten RK; Briles DE; Tuomanen EI; Paton JC
Clin Vaccine Immunol; 2015 Oct; 22(10):1079-89. PubMed ID: 26245351
[TBL] [Abstract][Full Text] [Related]
14. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
[TBL] [Abstract][Full Text] [Related]
15. Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.
Mann B; Thornton J; Heath R; Wade KR; Tweten RK; Gao G; El Kasmi K; Jordan JB; Mitrea DM; Kriwacki R; Maisonneuve J; Alderson M; Tuomanen EI
J Infect Dis; 2014 Apr; 209(7):1116-25. PubMed ID: 24041791
[TBL] [Abstract][Full Text] [Related]
16. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin.
Cruse G; Fernandes VE; de Salort J; Pankhania D; Marinas MS; Brewin H; Andrew PW; Bradding P; Kadioglu A
J Immunol; 2010 Jun; 184(12):7108-15. PubMed ID: 20483738
[TBL] [Abstract][Full Text] [Related]
17. Novel role for the Streptococcus pneumoniae toxin pneumolysin in the assembly of biofilms.
Shak JR; Ludewick HP; Howery KE; Sakai F; Yi H; Harvey RM; Paton JC; Klugman KP; Vidal JE
mBio; 2013 Sep; 4(5):e00655-13. PubMed ID: 24023386
[TBL] [Abstract][Full Text] [Related]
18. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
Hanniffy SB; Carter AT; Hitchin E; Wells JM
J Infect Dis; 2007 Jan; 195(2):185-93. PubMed ID: 17191163
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.
Hermand P; Vandercammen A; Mertens E; Di Paolo E; Verlant V; Denoël P; Godfroid F
Hum Vaccin Immunother; 2017 Jan; 13(1):220-228. PubMed ID: 27768518
[TBL] [Abstract][Full Text] [Related]
20. Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media.
Rapola S; Jäntti V; Haikala R; Syrjänen R; Carlone GM; Sampson JS; Briles DE; Paton JC; Takala AK; Kilpi TM; Käyhty H
J Infect Dis; 2000 Oct; 182(4):1146-52. PubMed ID: 10979911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
